Purdue Pharma Targeted Patients Knowing They Would Build Tolerance: Former Purdue Sales Rep.

Steve Lance
By Steve Lance
December 7, 2023Capitol Report

Purdue Pharma is offering to pay up to $6 billion to victims who say they got addicted to the company’s drugs. But the deal would protect the Sackler family, the owners of the drug maker, from future lawsuits.

On Dec. 4, the Supreme Court heard the opening arguments in the bankruptcy settlement case. How intentional were Purdue Pharma’s sales tactics? To find out we spoke with a former salesperson for Purdue Pharma, Carol Panara.


ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.